In Brief: Rochester Medical
This article was originally published in The Gray Sheet
Executive Summary
Rochester Medical: Gains 510(k) clearance March 13 to market a catheter that "has tremendous potential as a self-use female incontinence device and for use as a preferred replacement for Foley catheters in females." The catheter, which is "completely hand actuated," eliminates the need for syringes, "can be easily self-inserted and self-removed," and includes a retention mechanism that may be activated "by a simple squeeze of the fingers," according to the Stewartville, Minnesota-based company. The device is intended for use in hospitals, nursing facilities and the home. A launch date has not yet been set...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.